Au/SiNCA-based SERS analysis coupled with machine learning for the early-stage diagnosis of cisplatin-induced liver injury

Anal Chim Acta. 2023 May 8:1254:341113. doi: 10.1016/j.aca.2023.341113. Epub 2023 Mar 17.

Abstract

Cisplatin has been widely applied in the clinical treatment of various cancers, whereas liver injury induced by its hepatotoxicity is still a severe issue. Reliable identification of early-stage cisplatin-induced liver injury (CILI) can improve clinical care and help to streamline drug development. Traditional methods, however, cannot achieve enough information at the subcellular level due to the requirement of the labeling process and low sensitivity. To overcome these, we designed an Au-coated Si nanocone array (Au/SiNCA) to fabricate the microporous chip as the surface-enhanced Raman scattering (SERS) analysis platform for the early diagnosis of CILI. A CILI rat model was established, and the exosome spectra were obtained. The principal component analysis (PCA)-representation coefficient-based k-nearest centroid neighbor (RCKNCN) classification algorithm was proposed as the multivariate analysis method to build the diagnosis and staging model. The PCA-RCKNCN model has been validated to achieve a satisfactory result, with accuracy and AUC of over 97.5%, and sensitivity and specificity of over 95%, indicating that SERS combined with the PCA-RCKNCN analysis platform can be a promising tool for clinical applications.

Keywords: Liver injury; Machine learning; Microporous chip; Principal component analysis; Surface-enhanced Raman scattering.

MeSH terms

  • Animals
  • Chemical and Drug Induced Liver Injury, Chronic*
  • Cisplatin / toxicity
  • Early Detection of Cancer
  • Machine Learning
  • Metal Nanoparticles* / toxicity
  • Rats
  • Spectrum Analysis, Raman / methods

Substances

  • Cisplatin